Returning for a third year, the mRNA-Based Therapeutics Summit is the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines, and provides th
North America's Definitive Microbiome Drug Development Event Dedicated to Moving the Needle Forward on Microbial-Based Drug Development Innovation and Healthcare Industry Adoption.
A wide therapeutic index is the goal for all ADC developers, and whilst efficacy is undeniable, toxicity remains the single biggest factor in narrowing this window.